Citigroup Maintains Neutral on Hologic, Raises Price Target to $95

Hologic, Inc. +0.37%

Hologic, Inc.

HOLX

75.38

+0.37%

Citigroup analyst Patrick Donnelly maintains Hologic (NASDAQ: HOLX) with a Neutral and raises the price target from $80 to $95.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via